High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

Nature

Volumn 288, Issue 5788, 1980, Pages 273-275

  Sutherland, Robert L ^a   Murphy, Leigh C ^a   Foo, Ming San ^a   Green, Michael D ^a   Whybourne, Anne M ^a   Krozowski, Zygmunt S ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTIESTROGEN; CLOMIFENE; DRUG RECEPTOR; ESTRADIOL; ESTRADIOL H 3; ESTROGEN RECEPTOR; NAFOXIDINE; NITROMIFENE; NITROMIFENE H 3; RADIOISOTOPE; TAMOXIFEN; TAMOXIFEN H 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST; BREAST CARCINOMA; CHICKEN; ENDOMETRIUM; FEMALE GENITAL SYSTEM; IN VITRO STUDY; LIVER; MUSCLE; RAT; THEORETICAL STUDY; UTERINE TUBE; UTERUS;

ANIMALS; BREAST NEOPLASMS; CHICKENS; CYTOSOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; KIDNEY; LIVER; OVIDUCTS; RATS; RECEPTORS, DRUG; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; UTERUS;

ANIMALIA; GALLUS GALLUS;

EID: 0019297807     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/288273a0     Document Type: Article

References (21)

1. Katzenellenbogen, B. S. et al. Rec. Prog. Horm. Res. 35, 259–300 (1979).
2. Jordan, V. C., Dix, D. J., Naylor, K. E., Prestwich, G. & Rowsby, L. J. Tox. envir. Hlth 4, 363–390 (1978).
3. Mouridsen, H., Palshof, T., Patterson, J. & Battersby, L. Cancer Treat. Rev. 5, 131–141 (1978).
4. Horwitz, K. B. & McGuire, W. L. J. biol. Chem. 253, 8185–8191 (1978).
5. Lippman, M., Bolan, G. & Huff, K. Cancer Res. 36, 4595–4601 (1976).
6. Skidmore, J., Walpole, A. L. & Woodburn, J. J. Endocr. 52, 289–298 (1972).
7. Sutherland, R. L. & Foo, M. S. Biochem. biophys. Res. Commun. 91, 183–191 (1979).
8. Katzenellenbogen, B. S., Katzenellenbogen, J. A., Ferguson, E. R. & Krauthammer, N. J. biol. Chem. 253, 697–707 (1978).
9. Nicholson, R. I., Syne, J. S., Daniel, C. P. & Griffiths, K. Eur. J. Cancer 15, 317–329 (1979).
10. Capony, F. & Rochefort, H. Mol. cell. Endocr. 11, 181–198 (1978).
11. Sutherland, R. L. & Simpson-Morgan, M. W. J. Endocr. 65, 319–332 (1975).
12. Chamness, G. C. & McGuire, W. L. Steroids 26, 538–542 (1976).
13. Scatchard, G., Ann, N. Y. Acad. Sci. 51, 660–672 (1949).
14. Murphy, L. C. & Sutherland, R. L. J. Endocr. (in the press).
15. Sutherland, R. L. & Murphy, L. C. Eur. J. Cancer. (in the press).
16. Sutherland, R. L. & Foo, M. S. in Non-Steroidal Antioestrogens (eds Sutherland, R. L. & Jordan, V. C.) (Academic, Sydney, in the press).
17. Jordan, V. C., Collins, M. M., Rowsby, L. & Prestwich, G. J. Endocr. 75, 305–316 (1977).
18. Binart, N. et al. Biochem. biophys. Res. Commun. 91, 812–818 (1979).
19. Wakeling, A. E. & Slater, S. R. Cancer Treat. Rep. 63, 1150 (1979).
20. Faye, J. C., Lasserre, B. & Bayard, F. Biochem. biophys. Res. Commun. 93, 1225–1231 (1980).
21. Murphy, L. C. et al. in Non-Steroidal Antioestrogens (eds Sutherland, R. L. & Jordan, V. C.) (Academic, Sydney, in the press).